Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Lexirin cleared to enter phase I

May 17, 1996

Potential pancreatitis treatments reported by Snow Brand

May 10, 1996

Tobishi reports outstanding selectivity of it's CCK-A antagonist

May 10, 1996

James Black Foundation describes CCK-B/gastrin receptor antagonist

May 10, 1996

Plasmin/kallikrein inhibitors from Hisamitsu

May 3, 1996

Hepagene preliminary phase III results look positive

May 3, 1996

Somatix hepatitis therapy receives patent coverage

May 3, 1996

Dainippon reports anti-H. pylori compounds

April 26, 1996

Tanabe Seiyaku reports CCK-A antagonist for pancreatitis

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.